GuidelineMMWR. Morbidity and mortality weekly report2023

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.

Jefferson M Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.